Calendar

pharmadog

Week of Jan 5, 2026

Jan 8, 2026approval215d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

full page →ensartinib hydrochloride →fda approvals ↗

Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Jan 8, 2026approval215d agoSAPROPTERIN DIHYDROCHLORIDE — FDA approvalSAPROPTERIN DIHYDROCHLORIDE

Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

full page →SAPROPTERIN DIHYDROCHLORIDE →fda approvals ↗

Jan 8, 2026approval215d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 8, 2026approval215d agoMAGNESIUM SULFATE — FDA approvalMAGNESIUM SULFATE

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

full page →MAGNESIUM SULFATE →fda approvals ↗

Jan 8, 2026approval215d agoFLUCONAZOLE — FDA approvalDiflucan

Sponsor: FDC LTD. Form: TABLET. Route: ORAL

full page →Diflucan →fda approvals ↗

Jan 8, 2026approval215d agoFUROSEMIDE — FDA approvalFurosemide Sun

Sponsor: MICRO LABS. Form: INJECTABLE. Route: INJECTION

full page →Furosemide Sun →fda approvals ↗

Jan 8, 2026approval215d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 9, 2026approval214d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

Jan 9, 2026approval214d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

Sponsor: ABHAI LLC. Form: SOLUTION. Route: ORAL

full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗

Jan 9, 2026approval214d agoAMITRIPTYLINE HYDROCHLORIDE — FDA approvalAlgoTherapeutix SAS

Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 9, 2026approval214d agoVARENICLINE TARTRATE — FDA approvalMylan Pharmaceuticals Inc

Sponsor: UMEDICA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 9, 2026approval214d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BIOCON PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

Jan 9, 2026approval214d agoNEXLETOL (BEMPEDOIC ACID) — FDA approvalbempedoic acid

Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL

full page →bempedoic acid →fda approvals ↗

Jan 9, 2026approval214d agoNEXLIZET (BEMPEDOIC ACID) — FDA approval(bempedoic acid + ezetimibe)

Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL

full page →(bempedoic acid + ezetimibe) →fda approvals ↗

Jan 9, 2026approval214d agoPHYTONADIONE — FDA approvalSigyn Therapeutics, Inc.

Sponsor: SUNNY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Week of Jan 12, 2026

Jan 12, 2026approval211d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 12, 2026approval

← prev

page 1 of 23

Week of Jan 5, 2026

Week of Jan 12, 2026